Physician profile
Duncan B Ackerman
NPI 1508842154
$3,407.39
in general payments reported to CMS, 2019-2025
14 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $286 · 2021: $1,950 · 2022: $671 · 2023: $164 · 2024: $129 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $499.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lima USA, INC. | $2,345.32 | 2020-2023 | Smr Shoulder |
| Depuy Synthes Sales INC. | $297.70 | 2020-2025 | Na |
| Innovation Technologies INC | $140.18 | 2020-2023 | Irrisept |
| Kerecis Limited | $124.41 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $105.78 | 2022-2024 | Pico, Pico 7, Grafix Pl |
| Exactech, INC. | $93.82 | 2020 | |
| Limacorporate S.P.A. | $74.24 | 2022 | |
| Xtant Medical INC | $69.55 | 2022 | |
| Sioux Surgical INC | $42.06 | 2025 | |
| Zimmer Biomet Holdings, INC. | $34.55 | 2025 | Activbraid, Tapestry |
| Ethicon US, LLC | $32.51 | 2025 | Dermabond |
| Polynovo North America LLC | $17.82 | 2025 | Novosorb Btm |
| Amgen INC. | $15.61 | 2024 | Prolia, Evenity |
| Omeros Corporation | $13.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Duncan Ackerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.